Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that understanding health requires considering evolutionary perspectives on reproductive fitness, and recognizing the complexity of factors like diet, testosterone, and sexual orientation.

Early diagnosis and aggressive treatment are crucial for managing SLE-related pancreatitis in children.

Researchers identified five new potential targets for leishmaniasis treatment, suggesting repurposing existing drugs could be effective.

Myrtle has various health benefits and potential for medicine development.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

An 8-year-old girl had nail and hair issues that improved without specific treatment, but fungal nail infection was hard to cure.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

A 62-year-old woman with hair loss and scalp itching was diagnosed with lichen planopilaris, treated initially with topical corticosteroids, and other possible treatments include systemic steroids, antimalarials, and more.

Frontal fibrosing alopecia is a hair loss condition in postmenopausal women, similar to lichen planopilaris, with ineffective treatments.

Accurate diagnosis and aggressive treatment are crucial to prevent permanent hair loss in cicatricial alopecia.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

Early diagnosis and treatment of discoid lupus erythematosus improve outcomes.

Different hair care practices and conditions affect African American hair and scalp health, requiring specialized knowledge for treatment.

Lichen planopilaris mostly affects women with fair skin and can look different on each person, needing early treatment to prevent hair loss.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Sarcoidosis is more common and severe in Black patients than in Caucasians, requiring early diagnosis and treatment.

SLE patients in eastern Saudi Arabia have a generally good prognosis despite multi-organ involvement.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

Skin problems are common in lupus patients and should be treated early to prevent worsening.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Chronic cutaneous lupus erythematosus causes scarring, hair loss, and skin discoloration, especially on sun-exposed areas.

New treatments for Frontal Fibrosing Alopecia show promise, especially finasteride and dutasteride, with most patients seeing improvement or stabilization.

Hair transplantation for Frontal Fibrosing Alopecia may work if done after the disease is inactive for 2 years and with ongoing treatment after surgery.

Some medications can cause reversible hair loss by affecting hair growth cycles.

Best treatment for Frontal Fibrosing Alopecia is 5-alpha-reductase inhibitors and intralesional corticosteroids.